Nonclinical Features in Predictive Modeling of Cardiovascular Diseases: A Machine Learning Approach

Detection of cardiac abnormalities from 12-lead ecg using complex wavelet sub-band features

AIM OF THE STUDY

This research endeavours to optimize cardiac anomaly detection by introducing a method focused on selecting the most effective Daubechis wavelet families. The principal aim is to differentiate between cardiac states that are normal and abnormal by utilizing longer electrocardiogram (ECG) signal events based on the Apnea ECG dataset. Apnea ECG is often used to detect sleep apnea, a sleep disorder characterized by repeated interruptions in breathing during sleep. By using machine learning methods, such as Principal Component Analysis (PCA) and different classifiers, the goal is to improve the precision of cardiac irregularity identification. Used method. To extract important statistical and sub-band information from lengthy ECG signal episodes, the study uses a novel method that combines discrete wavelet transform with Principal Component Analysis (PCA) for dimension reduction. The methodology focuses on successfully categorizing ECG signals by utilizing several classifiers, including multilayer perceptron (MLP) neural network, Ensemble Subspace K-Nearest Neighbour(KNN), and Ensemble Bagged Trees, together with varied Daubechis wavelet families (db2, db3, db4, db5, db6). Brief Description of Results. The results emphasize the importance of the chosen Daubechis wavelet family, db5, and its superiority in ECG representation. The method distinguishes normal and abnormal ECG signals well on the Physionet Apnea ECG database. The Neural Network-based method accurately recognizes 100% of healthy signals and 97.8% of problematic ones with 98.6% accuracy.

FINDINGS

The Ensemble Subspace K-Nearest Neighbour (KNN) and Ensemble Bagged Trees methods got 87.1% accuracy and 0.89 and 0.87 AOC curve values on this dataset, showing that the method works. Precision values of 0.96, 0.86, and 0.86 for MLP Neural Network, KNN Subspace, and Ensemble Bagged Trees confirm their robustness. These findings suggest wavelet families and machine learning can improve cardiac abnormality detection and categorization.

An intelligent health monitoring and diagnosis system based on the internet of things and fuzzy logic for cardiac arrhythmia COVID-19 patients

BACKGROUND

During the COVID-19 pandemic, there is a global demand for intelligent health surveillance and diagnosis systems for patients with critical conditions, particularly those with severe heart diseases. Sophisticated measurement tools are used in hospitals worldwide to identify serious heart conditions. However, these tools need the face-to-face involvement of healthcare experts to identify cardiac problems.

OBJECTIVE

To design and implement an intelligent health monitoring and diagnosis system for critical cardiac arrhythmia COVID-19 patients.

METHODOLOGY

We use artificial intelligence tools divided into two parts: (i) IoT-based health monitoring; and (ii) fuzzy logic-based medical diagnosis. The intelligent diagnosis of heart conditions and IoT-based health surveillance by doctors is offered to critical COVID-19 patients or isolated in remote locations. Sensors, cloud storage, as well as a global system for mobile texts and emails for communication with doctors in case of emergency are employed in our proposal.

RESULTS

Our implemented system favors remote areas and isolated critical patients. This system utilizes an intelligent algorithm that employs an ECG signal pre-processed by moving through six digital filters. Then, based on the processed results, features are computed and assessed. The intelligent fuzzy system can make an autonomous diagnosis and has enough information to avoid human intervention. The algorithm is trained using ECG data from the MIT-BIH database and achieves high accuracy. In real-time validation, the fuzzy algorithm obtained almost 100% accuracy for all experiments.

CONCLUSION

Our intelligent system can be helpful in many situations, but it is particularly beneficial for isolated COVID-19 patients who have critical heart arrhythmia and must receive intensive care.

Cloud-based deep learning-assisted system for diagnosis of sports injuries

At both clinical and diagnostic levels, machine learning technologies could help facilitate medical decision-making. Prediction of sports injuries, for instance, is a key component of avoiding and minimizing injury in motion. Despite significant attempts to forecast sports injuries, the present method is limited by its inability to identify predictors. When designing measures for the avoidance of work-related accidents and the reduction of associated risks, the risk of injury to athletes is a crucial consideration. Various indicators are being evaluated to identify injury risk factors in a number of different methods. Consequently, this paper proposes a Deep Learning-assisted System (DLS) for diagnosing sports injuries using the Internet of Things (IoT) and the concept of cloud computing. The IoT sensors that compose the body area network collect crucial data for the diagnosis of sports injuries, while cloud computing makes available flexible computer system resources and computing power. This research examines the brain injury monitoring framework, uses an optimal neural network to forecast brain injury, and enhances the medical rehabilitation system for sports. Using the metrics accuracy, precision, recall, and F1-score, the performance of the proposed model is assessed and compared with current models.

Clinical and Laboratory Approach to Diagnose COVID-19 Using Machine Learning

Coronavirus 2 (SARS-CoV-2), often known by the name COVID-19, is a type of acute respiratory syndrome that has had a significant influence on both economy and health infrastructure worldwide. This novel virus is diagnosed utilising a conventional method known as the RT-PCR (Reverse Transcription Polymerase Chain Reaction) test. This approach, however, produces a lot of false-negative and erroneous outcomes. According to recent studies, COVID-19 can also be diagnosed using X-rays, CT scans, blood tests and cough sounds. In this article, we use blood tests and machine learning to predict the diagnosis of this deadly virus. We also present an extensive review of various existing machine-learning applications that diagnose COVID-19 from clinical and laboratory markers. Four different classifiers along with a technique called Synthetic Minority Oversampling Technique (SMOTE) were used for classification. Shapley Additive Explanations (SHAP) method was utilized to calculate the gravity of each feature and it was found that eosinophils, monocytes, leukocytes and platelets were the most critical blood parameters that distinguished COVID-19 infection for our dataset. These classifiers can be utilized in conjunction with RT-PCR tests to improve sensitivity and in emergency situations such as a pandemic outbreak that might happen due to new strains of the virus. The positive results indicate the prospective use of an automated framework that could help clinicians and medical personnel diagnose and screen patients.

Exploration of Black Boxes of Supervised Machine Learning Models: A Demonstration on Development of Predictive Heart Risk Score

Machine learning (ML) often provides applicable high-performance models to facilitate decision-makers in various fields. However, this high performance is achieved at the expense of the interpretability of these models, which has been criticized by practitioners and has become a significant hindrance in their application. Therefore, in highly sensitive decisions, black boxes of ML models are not recommended. We proposed a novel methodology that uses complex supervised ML models and transforms them into simple, interpretable, transparent statistical models. This methodology is like stacking ensemble ML in which the best ML models are used as a base learner to compute relative feature weights. The index of these weights is further used as a single covariate in the simple logistic regression model to estimate the likelihood of an event. We tested this methodology on the primary dataset related to cardiovascular diseases (CVDs), the leading cause of mortalities in recent times. Therefore, early risk assessment is an important dimension that can potentially reduce the burden of CVDs and their related mortality through accurate but interpretable risk prediction models. We developed an artificial neural network and support vector machines based on ML models and transformed them into a simple statistical model and heart risk scores. These simplified models were found transparent, reliable, valid, interpretable, and approximate in predictions. The findings of this study suggest that complex supervised ML models can be efficiently transformed into simple statistical models that can also be validated.

Development of Nonlaboratory-Based Risk Prediction Models for Cardiovascular Diseases Using Conventional and Machine Learning Approaches

Criticism of the implementation of existing risk prediction models (RPMs) for cardiovascular diseases (CVDs) in new populations motivates researchers to develop regional models. The predominant usage of laboratory features in these RPMs is also causing reproducibility issues in low–middle-income countries (LMICs). Further, conventional logistic regression analysis (LRA) does not consider non-linear associations and interaction terms in developing these RPMs, which might oversimplify the phenomenon. This study aims to develop alternative machine learning (ML)-based RPMs that may perform better at predicting CVD status using nonlaboratory features in comparison to conventional RPMs. The data was based on a case–control study conducted at the Punjab Institute of Cardiology, Pakistan. Data from 460 subjects, aged between 30 and 76 years, with (1:1) gender-based matching, was collected. We tested various ML models to identify the best model/models considering LRA as a baseline RPM. An artificial neural network and a linear support vector machine outperformed the conventional RPM in the majority of performance matrices. The predictive accuracies of the best performed ML-based RPMs were between 80.86 and 81.09% and were found to be higher than 79.56% for the baseline RPM. The discriminating capabilities of the ML-based RPMs were also comparable to baseline RPMs. Further, ML-based RPMs identified substantially different orders of features as compared to baseline RPM. This study concludes that nonlaboratory feature-based RPMs can be a good choice for early risk assessment of CVDs in LMICs. ML-based RPMs can identify better order of features as compared to the conventional approach, which subsequently provided models with improved prognostic capabilities.